Israel - Ibrani - Ministry of Health

astrazeneca (israel) ltd - sodium zirconium cyclosilicate - אבקה להכנת תרחיף - sodium zirconium cyclosilicate 5 g/sachet - sodium zirconium cyclosilicate

Israel - Ibrani - Ministry of Health

teva medical ltd - dextrose monohydrate; sodium chloride - תמיסה לאינפוזיה - sodium chloride 0.18 g / 100 ml; dextrose monohydrate 4.68 g / 100 ml - sodium chloride - sodium chloride - for replacing calories and electrolytes.

Israel - Ibrani - Ministry of Health

baxter healthcare distribution ltd., israel - calcium chloride dihydrate; disodium phosphate dihydrate; magnesium chloride hexahydrate; potassium chloride; sodium chloride; sodium hydrogen carbonate - תמיסה להמודיאליזה\המופילטרציה - disodium phosphate dihydrate 0.225 g/l; potassium chloride 0.314 g/l; sodium chloride 6.44 g/l; magnesium chloride hexahydrate 2.44 g/l; calcium chloride dihydrate 3.68 g/l; sodium hydrogen carbonate 2.92 g/l - combinations

Israel - Ibrani - Ministry of Health

novartis israel ltd - somatropin recombinant - תמיסה להזרקה - somatropin recombinant 10 mg / 1.5 ml - somatropin

Israel - Ibrani - Ministry of Health

novartis israel ltd - somatropin recombinant - תמיסה להזרקה - somatropin recombinant 15 mg / 1.5 ml - somatropin

Israel - Ibrani - Ministry of Health

masrouji co, ltd - somatropin recombinant - תמיסה להזרקה - somatropin recombinant 5 mg / 1.5 ml - somatropin

Israel - Ibrani - Ministry of Health

novartis israel ltd - epoetin alfa - תמיסה להזרקה - epoetin alfa 1000 iu / 0.5 ml - erythropoietin - erythropoietin - treatment of symptomatic anaemia associated with chronic renal failure (crf) in adult and paediatric patients:- treatment of anaemia associated with chronic renal failure in paediatric and adult patients on haemodialysis and adult patients on peritoneal dialysis.- treatment of severe anaemia of renal origin accompanied by clinical symptoms in adult patients with renal insufficiency not yet undergoing dialysis. treatment of anaemia and reduction of transfusion requirements in adult patients receiving chemotherapy for solid tumours, malignant lymphoma or multiple myeloma, and at risk of transfusion as assessed by the patient's general status (e.g. cardiovascular status, pre existing anaemia at the start of chemotherapy). binocrit can be used to increase the yield of autologous blood from patients in a predonation programme. its use in this indication must be balanced against the reported risk of thromboembolic events. treatment should only be given to non-iron deficient patients with moderate anaemia (haemoglob

Israel - Ibrani - Ministry of Health

novartis israel ltd - epoetin alfa - תמיסה להזרקה - epoetin alfa 2000 iu / 1 ml - erythropoietin - erythropoietin - treatment of symptomatic anaemia associated with chronic renal failure (crf) in adult and paediatric patients:- treatment of anaemia associated with chronic renal failure in paediatric and adult patients on haemodialysis and adult patients on peritoneal dialysis.- treatment of severe anaemia of renal origin accompanied by clinical symptoms in adult patients with renal insufficiency not yet undergoing dialysis. treatment of anaemia and reduction of transfusion requirements in adult patients receiving chemotherapy for solid tumours, malignant lymphoma or multiple myeloma, and at risk of transfusion as assessed by the patient's general status (e.g. cardiovascular status, pre existing anaemia at the start of chemotherapy). binocrit can be used to increase the yield of autologous blood from patients in a predonation programme. its use in this indication must be balanced against the reported risk of thromboembolic events. treatment should only be given to non-iron deficient patients with moderate anaemia (haemoglob

Israel - Ibrani - Ministry of Health

novartis israel ltd - epoetin alfa - תמיסה להזרקה - epoetin alfa 30000 iu / 0.75 ml - erythropoietin - erythropoietin - treatment of symptomatic anaemia associated with chronic renal failure (crf) in adult and paediatric patients:- treatment of anaemia associated with chronic renal failure in paediatric and adult patients on haemodialysis and adult patients on peritoneal dialysis.- treatment of severe anaemia of renal origin accompanied by clinical symptoms in adult patients with renal insufficiency not yet undergoing dialysis. treatment of anaemia and reduction of transfusion requirements in adult patients receiving chemotherapy for solid tumours, malignant lymphoma or multiple myeloma, and at risk of transfusion as assessed by the patient's general status (e.g. cardiovascular status, pre existing anaemia at the start of chemotherapy). binocrit can be used to increase the yield of autologous blood from patients in a predonation programme. its use in this indication must be balanced against the reported risk of thromboembolic events. treatment should only be given to non-iron deficient patients with moderate anaemia (haemoglob

Israel - Ibrani - Ministry of Health

novartis israel ltd - epoetin alfa - תמיסה להזרקה - epoetin alfa 4000 iu / 0.4 ml - erythropoietin - erythropoietin - treatment of symptomatic anaemia associated with chronic renal failure (crf) in adult and paediatric patients:- treatment of anaemia associated with chronic renal failure in paediatric and adult patients on haemodialysis and adult patients on peritoneal dialysis.- treatment of severe anaemia of renal origin accompanied by clinical symptoms in adult patients with renal insufficiency not yet undergoing dialysis. treatment of anaemia and reduction of transfusion requirements in adult patients receiving chemotherapy for solid tumours, malignant lymphoma or multiple myeloma, and at risk of transfusion as assessed by the patient's general status (e.g. cardiovascular status, pre existing anaemia at the start of chemotherapy). binocrit can be used to increase the yield of autologous blood from patients in a predonation programme. its use in this indication must be balanced against the reported risk of thromboembolic events. treatment should only be given to non-iron deficient patients with moderate anaemia (haemoglob